Arcus Biosciences earnings were -$270.0M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest RCUS earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$92.0M, down 1.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, RCUS reported annual earnings of -$307.0M, with 15% growth. The next RCUS earnings date is Feb 19, 2025.
What were Arcus Biosciences's earnings last quarter?
On RCUS's earnings call on Invalid Date, Arcus Biosciences (NYSE: RCUS) reported Q3 2024 earnings per share (EPS) of -$1.00, up 6.38% year over year. Total RCUS earnings for the quarter were -$92.00 million. In the same quarter last year, Arcus Biosciences's earnings per share (EPS) was -$0.94.
The next RCUS earnings call is Invalid Date. Add RCUS to your watchlist to be reminded of Arcus Biosciences's next earnings date.
What was RCUS's earnings growth in the past year?
As of Arcus Biosciences's earnings date in Invalid Date, Arcus Biosciences's earnings has grown year over year. RCUS earnings in the past year totalled -$270.00 million.
Is Arcus Biosciences profitable or losing money?
As of the last Arcus Biosciences earnings report, Arcus Biosciences is currently losing money. Arcus Biosciences's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$270.00 million, a 7.85% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.